The latest Life Sciences Competitiveness Indicators published by the UK government suggests that international investors are abandoning the country’s life scien 13 July 2023
A report commissioned by Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group representing big pharma in the USA, has highlighted the r 10 July 2023
German multi-modal biotech Evotec has agreed terms for a $74 million project, building on work it has been undertaking on behalf of the US Department of Defense 5 July 2023
Political and health leaders have signed and adopted the Nagasaki Outcomes Statement, calling for accelerated R&D, access, and delivery for neglected tropical d 4 July 2023
Russian state needs additional funds to ensure domestic generic productionRussian state needs additional funds to ensure domestic generic production 4 July 2023
The newly-elected presidency team of Europe’s leading trade body has met to discuss the industry’s growing concern over the impact of proposed changes to pharma 26 June 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.